ArticleFrontiers in immunology2021

An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy.

Yuta Izumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.